Literature DB >> 10922349

A-bomb survivors: factors that may lead to a re-assessment of the radiation hazard.

A M Stewart1, G W Kneale.   

Abstract

BACKGROUND: The study cohort of the survivors of the A-bombs in Japan, used as the basis of the internationally accepted estimates of cancer radiation risk, was collected more than 5 years after the bombing and did not include those who died of bomb-related injuries before that date. This paper tests whether the people who survived, in spite of bomb-related injuries, are homogeneous in respect of variation of cancer risk with age with survivors without such injuries.
METHODS: Appropriate statistical models are derived and fitted to survivor data by maximum likelihood and the resultant statistics used to test the homogeneity assumption.
RESULTS: Significant differences were found between those with no injuries and those with multiple injuries and shown to be largely due to exposures before 10 or after 55 years of age having exceptionally high risks of late effects of radiation for survivors showing early effects, i.e. bomb-related injuries.
CONCLUSIONS: Certain accepted dogmas about the biology of radiation risks in humans, such as 'cancer is the only late effect of radiation' and 'leukaemia is uniquely radiogenic amongst cancers', may be significantly in error. These are discussed.

Entities:  

Mesh:

Year:  2000        PMID: 10922349     DOI: 10.1093/ije/29.4.708

Source DB:  PubMed          Journal:  Int J Epidemiol        ISSN: 0300-5771            Impact factor:   7.196


  16 in total

Review 1.  Experimental radiation-induced heart disease: past, present, and future.

Authors:  Marjan Boerma
Journal:  Radiat Res       Date:  2012-06-04       Impact factor: 2.841

Review 2.  Space radiation and cardiovascular disease risk.

Authors:  Marjan Boerma; Gregory A Nelson; Vijayalakshmi Sridharan; Xiao-Wen Mao; Igor Koturbash; Martin Hauer-Jensen
Journal:  World J Cardiol       Date:  2015-12-26

3.  Age at exposure to ionising radiation and cancer mortality among Hanford workers: follow up through 1994.

Authors:  S Wing; D B Richardson
Journal:  Occup Environ Med       Date:  2005-07       Impact factor: 4.402

Review 4.  A review of non-cancer effects, especially circulatory and ocular diseases.

Authors:  Mark P Little
Journal:  Radiat Environ Biophys       Date:  2013-08-01       Impact factor: 1.925

5.  Missing doses in the life span study of Japanese atomic bomb survivors.

Authors:  David B Richardson; Steve Wing; Stephen R Cole
Journal:  Am J Epidemiol       Date:  2013-02-20       Impact factor: 4.897

6.  Possible selection effects for radiation risk estimates in Japanese A-bomb survivors: reanalysis of acute radiation symptoms data.

Authors:  Nezahat Hunter; Colin R Muirhead; Wei Zhang
Journal:  Radiat Environ Biophys       Date:  2006-03-25       Impact factor: 1.925

Review 7.  Effects of ionizing radiation on the heart.

Authors:  Marjan Boerma; Vijayalakshmi Sridharan; Xiao-Wen Mao; Gregory A Nelson; Amrita K Cheema; Igor Koturbash; Sharda P Singh; Alan J Tackett; Martin Hauer-Jensen
Journal:  Mutat Res Rev Mutat Res       Date:  2016-07-10       Impact factor: 5.657

8.  Positive associations between ionizing radiation and lymphoma mortality among men.

Authors:  David B Richardson; Hiromi Sugiyama; Steve Wing; Ritsu Sakata; Eric Grant; Yukiko Shimizu; Nobuo Nishi; Susan Geyer; Midori Soda; Akihiko Suyama; Fumiyoshi Kasagi; Kazunori Kodama
Journal:  Am J Epidemiol       Date:  2009-03-06       Impact factor: 4.897

9.  A priming dose of protons alters the early cardiac cellular and molecular response to (56)Fe irradiation.

Authors:  Samy S Ramadan; Vijayalakshmi Sridharan; Igor Koturbash; Isabelle R Miousse; Martin Hauer-Jensen; Gregory A Nelson; Marjan Boerma
Journal:  Life Sci Space Res (Amst)       Date:  2015-12-14

10.  Increase of regional total cancer incidence in north Sweden due to the Chernobyl accident?

Authors:  Martin Tondel; Peter Hjalmarsson; Lennart Hardell; Göran Carlsson; Olav Axelson
Journal:  J Epidemiol Community Health       Date:  2004-12       Impact factor: 3.710

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.